Global Longlife Hospital and Research
Healthcare Services
543520 BSE
₹13.95
Close ·
- P/E
- 7.75
Close 4 Nov 2026 ₹13.95 −11.53 −45.3% 1Y
Start ₹25.48
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures at the close · TTM
- ROCE
- −3.92%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹1.80
- Book Value
- ₹22.62
- Market Cap
- —
- P/E (TTM)
- 7.75
- P/B
- 0.62
- ROE
- −6.81%
- Dividend Yield
- 0.00%
- EBITDA
- −₹1.00 Cr
- 52W High
- ₹25.80
- 52W Low
- ₹9.00
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
43 Weak
Data confidence 100/100
Category scores
- Quality
- 26
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 67
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 1
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 73
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 62
- Good
- Trend strength, vol-adjusted 12% weight
- Ownership
- 35
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.59 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -22.9%
- Promoter holding is low: 0.02%
- Company has a low return on equity of -8.85% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 4 | 11 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bullish | 1 | 0 | 9 |
Oscillators
Bearish
Bearish
3
Neutral
4
Bullish
2
Overall
Strong Bullish
Bearish
4
Neutral
4
Bullish
11
Moving Averages
Strong Bullish
Bearish
1
Neutral
0
Bullish
9
Key readings
- RSI (14)
- 60.66
- Neutral
- MACD (12,26,9)
- 0.07
- Bullish
- SMA (50)
- 12.85
- Bullish
- SMA (200)
- 13.64
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | −100.00% |
|---|---|
| 3Y | −100.00% |
| 1Y | −100.00% |
Net profit
| 5Y | Turned to loss |
|---|---|
| 3Y | Turned to loss |
| 1Y | Turned to loss |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Outflow narrowed by ₹35.91 Cr |
| 1Y | Turned negative |
Operating margin· change in pp
| 5Y | No sales |
|---|---|
| 3Y | No sales |
| 1Y | Tiny sales |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2019 | ₹33.44 Cr |
|---|---|
| Mar 2020 | ₹33.32 Cr |
| Mar 2021 | ₹32.70 Cr |
| Mar 2022 | ₹32.44 Cr |
| Mar 2023 | ₹23.38 Cr |
| Mar 2024 | ₹13.46 Cr |
| Mar 2025 | ₹0.31 Cr |
| Mar 2026 | ₹0.00 Cr |
Net profit by year
| Mar 2019 | ₹1.36 Cr |
|---|---|
| Mar 2020 | −₹0.86 Cr |
| Mar 2021 | ₹2.05 Cr |
| Mar 2022 | ₹3.57 Cr |
| Mar 2023 | ₹1.83 Cr |
| Mar 2024 | −₹2.19 Cr |
| Mar 2025 | ₹0.20 Cr |
| Mar 2026 | −₹1.72 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.94 | 12.87 | 11.8 | 11.7 | 12.33 | 1.18 | 0.58 | 0 | 0 | 0 |
| Expenses | 13.18 | 11.61 | 10.03 | 9.44 | 9.62 | 4.2 | 4.39 | 0.35 | 0.6 | 0.4 |
| Operating Profit | 6.76 | 1.26 | 1.77 | 2.26 | 2.71 | −3.02 | −3.81 | −0.35 | −0.6 | −0.4 |
| OPM % | 33.9% | 9.79% | 15% | 19.32% | 21.98% | −255.93% | −656.9% | — | — | — |
| Other Income | 0.07 | 0.16 | 0.07 | 0.17 | 0.02 | 0.04 | 5.69 | −0.67 | 0.01 | 0 |
| Interest | 0.09 | 1.31 | 0.2 | 0.2 | 0.41 | 0.36 | 0.28 | 0 | 0 | 0 |
| Depreciation | 0.58 | 0.57 | 0.58 | 0.59 | 0.61 | 0.64 | 0.48 | 0 | 0 | 0 |
| PBT | 6.16 | −0.46 | 1.06 | 1.64 | 1.71 | −3.98 | 1.12 | −1.02 | −0.59 | −0.4 |
| Tax % | 0% | −78.26% | 29.25% | 35.37% | 39.77% | −19.1% | −11.61% | 2.94% | 123.73% | 0% |
| Net Profit | 6.17 | −0.1 | 0.76 | 1.07 | 1.03 | −3.22 | 1.24 | −1.04 | −1.32 | −0.4 |
| EPS (₹) | 8.81 | −0.14 | 0.72 | 1.02 | 0.98 | −3.07 | 1.18 | −0.99 | −1.26 | −0.38 |
Profit & Loss
₹ Cr| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 33.44 | 33.32 | 32.7 | 32.44 | 23.38 | 13.46 | 0.31 | 0 |
| Expenses | 26.61 | 29.88 | 27.26 | 24.14 | 19.3 | 13.68 | 4.45 | 1 |
| Operating Profit | 6.83 | 3.44 | 5.44 | 8.3 | 4.08 | −0.22 | −4.14 | −1 |
| OPM % | 20.42% | 10.32% | 16.64% | 25.59% | 17.45% | −1.63% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — |
| Other Income | 0.08 | 0.03 | 0.06 | 0.17 | 0.24 | 0 | 5.02 | 0.01 |
| Interest | 2.07 | 2.41 | 2.44 | 1.62 | 0.45 | 0.8 | 0.3 | 0 |
| Depreciation | 2.15 | 2.13 | 1.31 | 1.14 | 1.17 | 1.25 | 0.48 | 0 |
| PBT | 2.69 | −1.07 | 1.75 | 5.71 | 2.7 | −2.27 | 0.1 | −0.99 |
| Tax % | 49.07% | −18.69% | −16.57% | 37.3% | 32.59% | −3.52% | −100% | 73.74% |
| Net Profit | 1.36 | −0.86 | 2.05 | 3.57 | 1.83 | −2.19 | 0.2 | −1.72 |
| EPS (₹) | 1.94 | −1.23 | 2.93 | 5.1 | 1.74 | −2.09 | 0.19 | −1.64 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 10.5 | 10.5 | 10.5 | 10.5 |
| Reserves | 5.35 | 4.49 | 6.68 | 9.96 | 53.79 | 15.43 | 16.29 | 13.25 |
| Borrowings | 27.18 | 23.51 | 17.04 | 8.69 | 9.29 | 12.74 | 0 | 0 |
| Other Liabilities | 3.77 | 6.92 | 6.06 | 8.33 | 2.36 | 3.07 | 0.06 | 0.01 |
| Total Liabilities | 43.3 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
| Fixed Assets | 20.17 | 18.72 | 17.46 | 16.71 | 16.52 | 17.27 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 1.03 | 0 | 0 | 0 |
| Investments | 0.1 | 0.1 | 0.47 | 0.1 | 0.1 | 0.03 | 0.03 | 0 |
| Other Assets | 23.03 | 23.1 | 18.85 | 17.17 | 58.29 | 24.44 | 26.82 | 23.76 |
| Total Assets | 43.3 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
Cash Flow
₹ Cr| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | 5.4 | 3.9 | 6.88 | 9.42 | −40.42 | −5.07 | 12.32 | −4.51 |
| Investing | −0.33 | −0.04 | 0.02 | 0.01 | −1.9 | −0.82 | 21.8 | 0.04 |
| Financing | −4.77 | −3.05 | −7.22 | −9.66 | 45.7 | 2.67 | −13.01 | 0 |
| Net Cash Flow | 0.31 | 0.81 | −0.33 | −0.22 | 3.38 | −3.22 | 21.11 | −4.47 |
| Free Cash Flow | 5 | 3.79 | 6.84 | 8.96 | −42.42 | −6.1 | 33.42 | −4.51 |
| CFO/EBITDA | 79 | 113 | 126 | 105 | −960 | 2,259 | −304 | 401 |
Ratios
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94.85 | 68.68 | 87.51 | 100 | 151 | 52.88 | 377 | — |
| Inventory Days | 169 | 158 | 34.46 | 88.98 | 69.12 | 132 | 0 | — |
| Days Payable | 230 | 392 | 139 | 433 | 110 | 766 | — | — |
| Cash Conversion Cycle | 34.44 | −165 | −16.71 | −244 | 110 | −581 | 377 | — |
| Working Capital Days | 19.21 | 12.16 | 7.14 | −29.7 | 345 | −238 | 1,283 | — |
| ROCE % | — | 3.81% | 12.75% | 26.22% | 6.35% | −2.51% | −13.69% | −3.92% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Global Longlife Hospital and Research insights
50 extracted metrics across FY19–FY26.
Documents
Frequently Asked Questions about Global Longlife Hospital and Research
What does Global Longlife Hospital and Research Ltd do?
Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals
Where is Global Longlife Hospital and Research Ltd (GLHRL) listed?
Global Longlife Hospital and Research Ltd trades under code 543520 on the BSE.
Which sector does Global Longlife Hospital and Research Ltd belong to?
Global Longlife Hospital and Research Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the PE ratio of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd trades at a PE ratio of 7.75 as of 4 Nov 2026, on earnings per share of ₹1.8, against a book value of ₹22.62 per share.
What is the 52-week high and low of Global Longlife Hospital and Research Ltd?
Over the last 52 weeks Global Longlife Hospital and Research Ltd has traded between ₹9 and ₹25.8 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd reported a return on equity of -6.81%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543520.md for Global Longlife Hospital and Research Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.